These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 33264518)
1. N6-methyladenine-related genes affect biological behavior and the prognosis of glioma. Qu S; Chen Z; Liu B; Liu J; Wang H Cancer Med; 2021 Jan; 10(1):98-108. PubMed ID: 33264518 [TBL] [Abstract][Full Text] [Related]
2. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas. Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L Front Immunol; 2020; 11():603341. PubMed ID: 33363544 [TBL] [Abstract][Full Text] [Related]
3. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients. Hu Y; Tu Z; Lei K; Huang K; Zhu X Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238 [TBL] [Abstract][Full Text] [Related]
4. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas. Zhou Z; Wei J; Yang Z; Bao Y; Jiang W; Lu B; Wang W; Li L Sci Rep; 2022 Feb; 12(1):1872. PubMed ID: 35115572 [TBL] [Abstract][Full Text] [Related]
5. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma. Lvu W; Fei X; Chen C; Zhang B Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165 [TBL] [Abstract][Full Text] [Related]
6. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas. Chen J; Li Y; Han X; Pan Y; Qian X Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634 [TBL] [Abstract][Full Text] [Related]
7. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas. Wu Y; Peng Z; Gu S; Wang H; Xiang W Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111 [TBL] [Abstract][Full Text] [Related]
8. Ferroptosis-related gene signature as a prognostic marker for lower-grade gliomas. Zheng Y; Ji Q; Xie L; Wang C; Yu CN; Wang YL; Jiang J; Chen F; Li WB J Cell Mol Med; 2021 Mar; 25(6):3080-3090. PubMed ID: 33594759 [TBL] [Abstract][Full Text] [Related]
9. Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication. Fan Y; Peng X; Li B; Zhao G Biomed Res Int; 2020; 2020():1872962. PubMed ID: 32964017 [TBL] [Abstract][Full Text] [Related]
10. Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction. Qian Z; Li Y; Sun Z; Fan X; Xu K; Wang K; Li S; Zhang Z; Jiang T; Liu X; Wang Y Aging (Albany NY); 2018 Oct; 10(10):2884-2899. PubMed ID: 30362964 [TBL] [Abstract][Full Text] [Related]
11. Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma. He J; Zeng C; Long Y Comput Math Methods Med; 2021; 2021():2191709. PubMed ID: 34497663 [TBL] [Abstract][Full Text] [Related]
12. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma. Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K Front Oncol; 2020; 10():1119. PubMed ID: 32974125 [No Abstract] [Full Text] [Related]
13. Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma. Zeng F; Wang K; Liu X; Zhao Z Cell Commun Signal; 2020 Jan; 18(1):2. PubMed ID: 31907037 [TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of multi-omics data reveals a pseudouridine-related lncRNA signature for prediction of glioma prognosis and chemoradiotherapy sensitivity. Yang Y; Wang F; Teng H; Zhang C; Zhang Y; Chen P; Li Q; Kan X; Chen Z; Wang Z; Yu Y Comput Biol Med; 2023 Nov; 166():107428. PubMed ID: 37748218 [TBL] [Abstract][Full Text] [Related]
15. Establishment of a nomogram with EMP3 for predicting clinical outcomes in patients with glioma: A bi-center study. Zhang A; Xu H; Zhang Z; Liu Y; Han X; Yuan L; Ni Y; Gao S; Xu Y; Chen S; Jiang J; Chen Y; Zhang X; Lou M; Zhang J CNS Neurosci Ther; 2021 Oct; 27(10):1238-1250. PubMed ID: 34268874 [TBL] [Abstract][Full Text] [Related]
16. Machine learning-based identification of a cell death-related signature associated with prognosis and immune infiltration in glioma. Zhou Q; Wu F; Zhang W; Guo Y; Jiang X; Yan X; Ke Y J Cell Mol Med; 2024 Jun; 28(11):e18463. PubMed ID: 38847472 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis. Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353 [TBL] [Abstract][Full Text] [Related]
18. Identification of Critical m Zheng J; Wang X; Qiu Y; Wang M; Yu H; Zhou Z; Wu Z; Jiang X Biomed Res Int; 2021; 2021():9959212. PubMed ID: 34212046 [TBL] [Abstract][Full Text] [Related]
19. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas. Liu J; Li G Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726 [TBL] [Abstract][Full Text] [Related]
20. Seven genes for the prognostic prediction in patients with glioma. Zhang GH; Zhong QY; Gou XX; Fan EX; Shuai Y; Wu MN; Yue GJ Clin Transl Oncol; 2019 Oct; 21(10):1327-1335. PubMed ID: 30762207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]